Science Explorer Interactive view Map
Research facility · Heidelberg · Germany

Deutsches Konsortium für Translationale Krebsforschung

In research, Deutsches Konsortium für Translationale Krebsforschung stands highest in Life Sciences (#1,295 of 7,800 worldwide), Medicine (#1,746 of 10,443 worldwide) and Health Sciences (#2,500 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology, Immunology and Radiology, Nuclear Medicine and Imaging — Oncology is 12.3× its share of world research.

World rank, 2022–2025
#2,701
of 28,054 · #4,739 all time
Rank in Germany
#134
of 1,178
Research works
1k
▲ 158% vs 2013–17
Citations
40k
38.1 per fractional work
Top-10% rate
31.4%
record average 16.5%
Open access
74%
world 28%

What is Deutsches Konsortium für Translationale Krebsforschung known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Life SciencesDomain #1,295 of 7,800 31.8%115 #2214
MedicineField #1,746 of 10,443 30.8%240 #2552
Health SciencesDomain #2,500 of 11,982 30.9%243 #3498
Biochemistry, Genetics and Molecular BiologyField #1,864 of 3,579 31.5%80 #2916

Each strip is that field’s whole ranked pool, with the notch where Deutsches Konsortium für Translationale Krebsforschung sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Life Sciences#2,214 #1,295
  2. Medicine#2,552 #1,746
  3. Health Sciences#3,498 #2,500
  4. Biochemistry, Genetics and Molecular Biology#2,916 #1,864
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Deutsches Konsortium für Translationale Krebsforschung specialise in?

Where its research is concentrated relative to its size: Oncology takes 12.3× the share of its output that it takes of world research.

  1. OncologySubfield · 54.5 works12×
  2. ImmunologySubfield · 26.8 works9.9×
  3. Radiology, Nuclear Medicine and ImagingSubfield · 34.1 works9.6×
  4. Pulmonary and Respiratory MedicineSubfield · 45.5 works7.5×
  5. Immunology and MicrobiologyField · 27.2 works6.9×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.81× its world share, 80 worksBiochemistry, Geneti…Immunology and Microbiology: 6.86× its world share, 27 worksImmunology and Micro…Neuroscience: 0.92× its world share, 6 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.73× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.58× its world share, 4 worksChemistryComputer Science: 0.20× its world share, 6 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Energy: 0.02× its world share, 0 worksEnergyEngineering: 0.13× its world share, 8 worksEngineeringEnvironmental Science: 0.03× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.18× its world share, 2 worksMaterials ScienceMathematics: 0.22× its world share, 1 worksMathematicsPhysics and Astronomy: 1.37× its world share, 12 worksPhysics and AstronomyDentistry: 0.38× its world share, 1 worksDentistryHealth Professions: 0.11× its world share, 1 worksHealth ProfessionsMedicine: 3.17× its world share, 240 worksMedicineNursing: 0.34× its world share, 1 worksNursingVeterinary: 0.07× its world share, 0 worksVeterinaryDecision Sciences: 0.11× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.07× its world share, 1 worksEconomics, Econometr…Psychology: 0.07× its world share, 1 worksPsychologySocial Sciences: 0.01× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 6.9×. Every wedge is a field page.

Which keywords describe research at Deutsches Konsortium für Translationale Krebsforschung?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Radiotherapy, Cancer, Prognostic Factors, Tumor Microenvironment, Genetic Mutations and Targeted Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy62▲ 22×18 topics
  2. Cancer32▲ 6.0×44 topics
  3. Chemotherapy30▲ 11×21 topics
  4. Radiotherapy29▲ 19×12 topics
  5. Prognostic Factors26▲ 15×14 topics
  6. Tumor Microenvironment26▲ 15×8 topics
  7. Genetic Mutations22▲ 13×18 topics
  8. Targeted Therapy20▲ 23×5 topics
  9. Cancer Immunotherapy20▲ 33×3 topics
  10. Molecular Classification19▲ 31×4 topics
  11. Cancer Therapy18▲ 8.0×16 topics
  12. Biomarkers17▲ 6.2×14 topics
  13. Dosimetry16▲ 60×2 topics
  14. Clinical Trials16▲ 6.0×10 topics
  15. Lymphoma16▲ 25×4 topics
  16. Glioblastoma16▲ 58×1 topic
  17. Temozolomide16▲ 58×1 topic
  18. PET Imaging15▲ 22×4 topics
  19. Immunity14▲ 9.0×8 topics
  20. Tumor Regression14▲ 33×2 topics
  21. Leukemia13▲ 38×2 topics
  22. Precision Medicine13▲ 7.0×8 topics
  23. CAR T Cells12▲ 43×1 topic
  24. Chimeric Antigen Receptor12▲ 43×1 topic
  25. Gene Expression12▲ 5.2×15 topics
  26. Clinical Practice Guidelines12▲ 5.7×10 topics
  27. Prostate Cancer12▲ 24×4 topics
  28. Metastasis12▲ 9.0×12 topics
  29. Medical Imaging12▲ 5.8×7 topics
  30. Genomic Instability11▲ 25×3 topics
  31. Monte Carlo Simulation10▲ 13×3 topics
  32. Image-Guided Radiotherapy10▲ 60×1 topic
  33. Radiosurgery10▲ 27×4 topics
  34. Radiotherapy Physics10▲ 60×1 topic
  35. Innate Immunity10▲ 7.7×10 topics
  36. Survival Analysis10▲ 9.1×6 topics
  37. Radiation Therapy10▲ 18×6 topics
  38. Genomic Profiling9▲ 23×2 topics
  39. Immune Checkpoint Blockade9▲ 22×1 topic
  40. Quantitative Analysis9▲ 12×2 topics

Which research topics does Deutsches Konsortium für Translationale Krebsforschung publish most on?

By volume in 2022–2025: Glioma Diagnosis and Treatment, CAR-T cell therapy research, Advanced Radiotherapy Techniques and Cancer Immunotherapy and Biomarkers.

  1. 1 Glioma Diagnosis and Treatment Genetics 16 works
  2. 2 CAR-T cell therapy research Oncology 12 works
  3. 3 Advanced Radiotherapy Techniques Radiation 10 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 9 works
  5. 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 8 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 8 works
  7. 7 Immune Cell Function and Interaction Immunology 7 works
  8. 8 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 7 works
  9. 9 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 7 works
  10. 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 7 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.8%not open26.2%

World: 28% of research is openly available.

with international co-authors41.6%domestic only58.4%

World: 19% is written across borders.

How has Deutsches Konsortium für Translationale Krebsforschung's research output changed?

Output in 2018–2022 was 158% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Heidelberg

All research institutions in Heidelberg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.